BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 27249794)

  • 21. Gene expression of thyroid-specific transcription factors may help diagnose thyroid lesions but are not determinants of tumor progression.
    Batista FA; Ward LS; Marcello MA; Martins MB; Peres KC; Torricelli C; Bufalo NE; Soares FA; da Silva MJ; Assumpção LV
    J Endocrinol Invest; 2016 Apr; 39(4):423-9. PubMed ID: 26370671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MYC promotes the development of papillary thyroid carcinoma by inhibiting the expression of lncRNA PAX8‑AS1:28.
    Zhang Y; Li F; Chen J
    Oncol Rep; 2019 Apr; 41(4):2511-2517. PubMed ID: 30720110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GLIS Rearrangement is a Genomic Hallmark of Hyalinizing Trabecular Tumor of the Thyroid Gland.
    Nikiforova MN; Nikitski AV; Panebianco F; Kaya C; Yip L; Williams M; Chiosea SI; Seethala RR; Roy S; Condello V; Santana-Santos L; Wald AI; Carty SE; Ferris RL; El-Naggar AK; Nikiforov YE
    Thyroid; 2019 Feb; 29(2):161-173. PubMed ID: 30648929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Key genes and pathways predicted in papillary thyroid carcinoma based on bioinformatics analysis.
    Yu J; Mai W; Cui Y; Kong L
    J Endocrinol Invest; 2016 Nov; 39(11):1285-1293. PubMed ID: 27250077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trisomy 17 as a marker for a subset of noninvasive thyroid nodules with focal features of papillary carcinoma: cytogenetic and molecular analysis of 62 cases and correlation with histological findings.
    Frau DV; Lai ML; Caria P; Dettori T; Coni P; Faa G; Morandi L; Tallini G; Vanni R
    J Clin Endocrinol Metab; 2008 Jan; 93(1):177-81. PubMed ID: 17956956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of PAX8 Target Genes in Papillary Thyroid Carcinoma.
    Rosignolo F; Sponziello M; Durante C; Puppin C; Mio C; Baldan F; Di Loreto C; Russo D; Filetti S; Damante G
    PLoS One; 2016; 11(6):e0156658. PubMed ID: 27249794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From nodule to differentiated thyroid carcinoma: contributions of molecular analysis in 2012.
    Albarel F; Conte-Devolx B; Oliver C
    Ann Endocrinol (Paris); 2012 Jun; 73(3):155-64. PubMed ID: 22503804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RAS Mutations, and RET/PTC and PAX8/PPAR-gamma Chromosomal Rearrangements Are Also Prevalent in Benign Thyroid Lesions: Implications Thereof and A Systematic Review.
    Najafian A; Noureldine S; Azar F; Atallah C; Trinh G; Schneider EB; Tufano RP; Zeiger MA
    Thyroid; 2017 Jan; 27(1):39-48. PubMed ID: 27750019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The molecular basis of thyroid epithelial tumorigenesis.
    Bongarzone I; Pierotti MA
    Tumori; 2003; 89(5):514-6. PubMed ID: 14870774
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.